Follow the Sun Pharma Advanced Research Company Limited stock price and the full management transaction log of the company, a listed equity based in India. Shares are listed on IN IN, under the supervision of SEBI (PIT + SAST). Operating in the Health Care sector, Sun Pharma Advanced Research Company Limited has published 13 insider filings. Market capitalisation: €48bn. The latest transaction was filed on 23 February 2023 (Pledge). Among the most active insiders: Raksha S Valia. The full history is free.
13
Insider Decl.
0
Thresholds
€69m
3 ops.
Buy Volume
·
2 ops.
Sell Volume
14Σ signal
Buys €69m· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 739 of 26,213 companies
82.4
score / 100
Value
70
Quality
95
FCF yld-2.9%
Earn yld17%
EV/EBITDA6.0x
ROE277%
Gross mgn98%
Net mgn83%
Debt/EBITDA0.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.